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Temporal Development of Gut 
Microbiota in Triclocarban Exposed 
Pregnant and Neonatal Rats
Rebekah C. Kennedy1,2,*, Russell R. Fling3,*, Michael S. Robeson4,5, Arnold M. Saxton6, 
Robert L. Donnell7, John L. Darcy8, David A. Bemis7, Jiang Liu3, Ling Zhao9 & Jiangang Chen1
Alteration of gut microbial colonization process may influence susceptibility of the newborn/infant 
to infectious and chronic disease. Infectious disease risk leads to widespread use of non-prescription 
antimicrobials in household products such as Triclocarban (TCC), an antimicrobial compound in 
personal care products. TCC concentrates in and is transferred through the milk to suckling offspring. 
TCC exposure during gestation and lactation significantly reduced phylogenetic diversity (PD) 
among exposed dams and neonates. Among dams using weighted UniFrac distances, TCC induced 
significant dysbiosis of gut microbiota by gestational day (GD) 18, a trend that continued after delivery. 
Similarly, an overall restructuring of gut microbiota occurred in neonates. By postnatal day (PND) 12, 
communities separated based on exposure status and became significantly different at PND 16. The 
ability of TCC to drive microbial dysbiosis warrants future investigation to evaluate the safety of non-
prescription antimicrobial use, including TCC, during critical exposure windows.
Though it has commonly been estimated that bacteria cells outnumber human cells 10 to 1, more recent estimates 
suggest that a 1 to 1 ratio may be a more appropriate calculation1. The collective gut microbiota can act as an 
“ancillary organ” with a critical function in human health including regulation of host metabolism and energy 
balance, immune function stimulation, maintenance of host nutritional physiological homeostasis, and defense 
against pathogens2,3. Indigenous gut microorganisms occupy available intestinal niches, therefore any transient 
species derived from the environment will not colonize and will instead pass through the gastrointestinal system4. 
In contrast, alteration or imbalance of the composition of commensal bacterial population could induce transient 
or permanent damage to the host with profound health consequences5.
At birth, microbial colonization is largely a product of the host environment and is tied to a variety of factors 
including delivery (vaginal/caeseran) and infant feeding mode (breast/formula feeding)6,7. The evolvement of 
infant gut microbial composition is dynamic with large community shifts that occur at transitional stages, i.e. 
when solid foods are introduced or during early exposure to prescription antibiotics8,9. Close to the conclusion 
of the first year, the infant acquires a less dynamic gut microbial community that gradually converges to a more 
adult-like profile8.
The composition of the gut microflora can have a broad impact on the health of the host; it is well established 
that prescription antibiotic exposure can disrupt the balance of the intestinal microbiota potentially leading to 
unintentional side-effects; alteration of the colonization process may influence susceptibility of newborn/infant 
to infectious disease in the short-term and lead to immune mediated and metabolic disorders later in life3,5. More 
than 40% of pregnant women are prophylactically prescribed antibiotics during pregnancy/birth for preven-
tion of preterm labor, intrapartum fever, vertical pathogen transmission to the infant, and maternal morbidity 
after caesarean section10. While the average pregnant or lactating female does not control the use of prescription 
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antibiotics, precaution and fear of infectious disease outbreak in human populations leads to widespread use of 
non-prescription antimicrobials in household products11,12. It is estimated that more than 10 million women are 
either pregnant or lactating in the United States at any given time and the use of antimicrobial personal care prod-
ucts occurs among this population without confidence in the safety of antimicrobial exposure during early-life 
periods11–13. Specifically, the impact of early-life non-prescription antimicrobial compound exposure on both 
intestinal microbiota community integrity and the resultant health outcomes are understudied.
Triclocarban (3,4,4′ -trichlorocarbanilide; TCC) is a high production volume antimicrobial, used in personal 
care products, at a mass of up to 1.5% in certain brands of bar soaps11,14. TCC can be absorbed through the 
skin and has been detected in adult human urine, serum and in cord blood indicating exposure throughout the 
lifespan15–17. Volunteers with frequent exposure through the application of TCC containing products tend to have 
a higher TCC body burden in the circulation18. Recent evidence demonstrates that human exposure to TCC may 
not be limited to the purposeful use of antimicrobial products, but could occur through the diet19. Following 
incomplete removal by wastewater treatment process, TCC is detected in nutrient-rich sludge that may be applied 
as agricultural fertilizer leading to safety concerns regarding the potential intake through the food chain20.
Previously our group reported that TCC concentrates in the breast milk after dietary exposure in a rodent 
model indicating potential neonatal TCC exposure via lactation21. Furthermore, neonates with TCC exposure 
during lactation had distended gastrointestinal tracts with liquid, mustard-colored diarrhea implying the distur-
bance of intestinal microbiota and hence a dysbiotic status. In this report, we utilized a rodent model to inves-
tigate and characterize the temporal dynamics of intestinal microbiota in pregnant dams and neonatal rats in 
response to TCC exposure during gestation and lactation.
Results
Influence of Gestational and Lactational TCC Exposure on Dam Fecal Microbiota. Alpha and 
Beta Diversity. After quality filtering and removal of any OTU present at less than 0.005% of the total read 
count, 54 samples comprised of 4,931,803 sequences remained with an average of 91,330 sequences per sample. 
Neither Shannon’s index nor phylogenetic diversity differed between control and exposed dams prior to TCC 
exposure at baseline (GD 4). TCC exposure significantly reduced the diversity of microbiota in feces of treated 
animals compared to controls at 7 days after treatment (GD 11: Shannon 4.93 ± 0.088 vs 3.73 ± 0.180, Fig. 1A; 
PD 26.5 ± 0.338 vs 21.7 ± 0.277, Fig. 1B). This trend continued throughout gestation after 14 days of treatment at 
GD 18 (Shannon 4.97 ± 0.077 vs 3.50 ± 0.123, Fig. 1A; PD 25.9 ± 0.204 vs 19.1 ± 0.522, Fig. 1B) and into lactation 
16 days after delivery (AD 16), corresponding to 34 days of TCC exposure when both measures were signifi-
cantly suppressed in the exposed dams compared to controls (Shannon 4.59 ± 0.109 vs 4.14 ± 0.051, Fig. 1A; PD 
25.9 ± 0.143 vs 19.4 ± 0.272, Fig. 1B; two-way ANOVA, p < 0.05).
Increasing microbial community dissimilarity of TCC exposed vs control dams was pronounced at GD11 
and maintained over time (Fig. 2, Supplementary Fig. S1). Microbiota structure became statistically dissimilar 
by 14 days of treatment (GD 18; R2 = 0.69, Adonis p < 0.05) and remained different until AD 16 (34 days of TCC 
exposure; R2 = 0.69, Adonis p < 0.05). Repeated measures analysis revealed a significant interaction between time 
and treatment (R2 = 0.27, Adonis p < 0.05). Post-hoc analysis demonstrated that a significant time-treatment 
interaction occurred beginning at GD 11 after which microbial communities in control and treatment dams 
behaved differently.
Fecal Microbiota Community Composition. Figure 3 shows the relative abundance of the gut microbial com-
munity composition of dams over time, during pregnancy and lactation. Visually, the effect of TCC was more 
pronounced at the family than the phylum level (Fig. 3A,B). Across the study period in control dams, S24-7 
dominated fecal microbiota. While the Bacteroideaceae family was overrepresented in the microbiota of dams 
Figure 1. Alpha diversity of dams during gestation and lactation. Shannon’s diversity index (A) and 
phylogenetic diversity (B) is shown at Gestational day (GD) 4 (baseline), 11, 18 and 16 days after delivery (AD) 
(control: gray bar, 0.1% w/w TCC: black bar; n = 4/group). Data represent mean ± SEM of each group. Data 
were analyzed with two-way ANOVA with repeated measures followed by Bonferroni post-hoc test. Statistical 
significance was set at p = 0.05; (*) indicates statistical significance at each time point relative to controls.
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exposed to 0.1% w/w TCC. Significant differences at the phylum and family level across time and exposure groups 
are shown in Tables 1 and 2 respectively.
Figure 2. Beta diversity of dams during gestation and lactation. Pairwise weighted UniFrac distance between 
TCC exposed and control dams is shown among dams at Gestational Days (GD) 4 (baseline), 11, 18 and 16 days 
after delivery (AD); n = 4/group. Statistical significance of community level microbial distance was analyzed 
with Adonis, in the Vegan package, at each collection date50,51. Repeated measures analysis was conducted 
and significant time-treatment interactions were investigated with the Vegan package. (*) indicates statistical 
significance at each time point relative to controls.
Figure 3. Relative abundance of bacteria among dams at the phylum (A) and family (B) levels by collection 
date at GDs 4 (baseline), 11, 18 and 16 days after delivery (AD) (n = 4/group). At the family level, only the top 
100 OTUs are shown. Taxon labeled within square brackets indicate GreenGenes proposed taxonomy.
www.nature.com/scientificreports/
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Influence of Gestational and Lactational TCC Exposure on Neonatal Microbiota. Alpha and Beta 
Diversity. Among neonates, Shannon’s index did not differ between the two groups across the study period 
Fig. 4A. Phylogenetic diversity became significantly different on PND 16 (PD 19.51 ± 0.59 vs 9.18 ± 1.35 Fig. 4B; 
ANCOVA, p < 0.05). The effect of TCC exposure on beta diversity is shown in Fig. 5 and Supplementary Fig. S2 
using weighted UniFrac distances. Regardless of treatment status, an initial stochastic pattern emerged at PND 3 
followed by convergence at PND 6. After PND 6, the weighted UniFrac distances behaved similarly between con-
trol and exposed groups. By PND 12, separation based on treatment status occurred which became significantly 
different at PND 16 (R2 = 0.87, Adonis p < 0.05). Repeated measures analysis revealed an effect of collection date 
(R2 = 0.25).
Given the pattern of diversity shown in Fig. 5 and Supplementary Fig. S2, where a variable configuration 
arises at PND 3, followed by reorganization and subsequent separation based on exposure status coupled with 
Phylum* Stain Group
Least Squares Means**
GD 4 GD 11 GD 18 AD 16
BacteroidetesC Gram − 
Control 42.6 24.6 30.7 46.4
Exposed 41.1 39.3 65.2 20.6
FirmicutesC Gram + 
Control 48.0 71.9 65.5 48.7
Exposed 56.0 56.4 30.1 69.5
ProteobacteriaABC Gram − 
Control 2.7 < 1 2.0 2.1
Exposed 1.3 4.1 4.3 9.3
TenericutesAB Gram − 
Control 2.5 1.4 < 1 1.7
Exposed 1.1 < 1 < 1 < 1
Table 1. Effect of TCC on Relative Abundance of Dam Gut Microbial Phyla. A = Effect of time, p < 0.05; 
B = Effect of treatment, p < 0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1% 
of the relative abundance. **Least squares means displayed as percentage; GD = gestational day; AD = after 
delivery.
Family* Stain
Least Squares Means**
Group GD4 GD 11 GD 18 AD 16
[Paraprevotellaceae]ABC Gram − 
Control < 1 < 1 < 1 < 1
Exposed < 1 1.5 4.5 < 1
AlcaligenaceaeC Gram − 
Control 2.1 < 1 1.3 < 1
Exposed < 1 2.7 2.0 < 1
BacteroidaceaeABC Gram − 
Control 2.5 3.8 7.7 7.3
Exposed 1.1 34.8 56.1 18.9
ClostridiaceaeB Gram + 
Control 2.0 3.8 3.4 2.4
Exposed 1.2 < 1 < 1 < 1
DesulfovibrionaceaeABC Gram − 
Control < 1 < 1 < 1 < 1
Exposed < 1 < 1 2.0 2.5
EnterobacteriaceaeABC Gram − 
Control < 1 < 1 < 1 < 1
Exposed < 1 < 1 < 1 6.0
LactobacillaceaeB Gram + 
Control 1.5 3.2 1.6 4.4
Exposed 2.2 < 1 < 1 1.7
PorphyromonadaceaeABC Gram − 
Control 1.5 < 1 < 1 < 1
Exposed < 1 2.8 4.2 1.3
RikenellaceaeBC Gram − 
Control < 1 2.8 1.9 4.3
Exposed < 1 < 1 < 1 < 1
RuminococcaceaeAC Gram + 
Control 18.9 17.8 19.6 15.8
Exposed 16.8 33.8 10.1 21.4
S24− 7ABC Uncultured
Control 37.4 14.9 18.5 32.5
Exposed 38.5 < 1 < 1 < 1
TuricibacteraceaeAB Gram + 
Control 1.1 1.0 1.1 < 1
Exposed 1.1 < 1 < 1 < 1
Table 2. Effect of TCC on Relative Abundance of Dam Gut Microbial Families. A = Effect of time, p < 0.05; 
B = Effect of treatment, p < 0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1% 
of the relative abundance; **Least squares means displayed as percentage; GD = gestational day; AD = after 
delivery.
www.nature.com/scientificreports/
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the common assumption that microbiota is transferred early on from maternal sources to neonates, we sought 
to understand microbial similarity between dam samples collected near birth and neonate samples collected 
throughout the study period. To do so, we further compared weighted UniFrac distances of neonatal samples 
during lactation in relation to dam samples at GD 18. Figure 6A demonstrates initial clustering between control 
dams at GD 18 and control neonates at PND 3; neonatal diversity then reorganized, moving away from dams 
at PND 6 and again clustered more closely with dams at PND 12 and PND 16. The visualization between TCC 
exposed dams and exposed neonates is shown in Fig. 6B. Note that samples of exposed neonates were isolated 
away from dams at all time points.
Cecum Microbiota Community Composition. Relative abundance of microbiota present in neonate samples 
revealed a dominance by three phyla: Proteobacteria, Firmicutes, and Bacteroidetes regardless of collection date or 
treatment status (Fig. 7A). While increases in the proportion of Bacteroidaceae are noted in microbiota collected 
from control samples, Enterobacteriaceae dominated samples collected from neonates suckled by 0.1% w/wTCC 
exposed dams (Fig. 7B). Significant differences at the phylum and family level across time and exposure groups 
are shown in Table 3 and Table 4 respectively.
TCC Exposure on Pathology of Neonatal Gastrointestinal Tract. Grossly, TCC exposure during ges-
tation and lactation led to enlarged abdomens with mustard colored diarrhea in neonates. The formalin fixed gut 
of a control and an exposed neonate at PND 12 are shown in Fig. 8A,B respectively. Compared to controls, the 
gastrointestinal tracts of TCC exposed neonates were filled with gas and liquid. H&E staining of the large (cecum) 
Figure 4. Alpha diversity of neonates during lactation period. Shannon’s diversity index (A) and phylogenetic 
diversity (B) is shown at postnatal days (PND) 3, 6, 12 and 16 (control: gray bar, 0.1% w/w TCC: black 
bar; n = 3/group). Data represent mean ± SEM of each group. ANCOVA at each individual time point was 
conducted using alpha diversity of dams at GD 18 as the covariate for phylogenetic diversity and Shannon’s 
index followed by Bonferroni post hoc test. Statistical significance was set at p = 0.05; (*) indicates statistical 
significance at each time point relative to controls.
Figure 5. Beta diversity of neonates during lactation period. Pairwise weighted UniFrac distance between 
TCC exposed and control neonates is shown at postnatal days (PND) 3, 6, 12 and 16 (n = 3/group). Community 
level statistical significance was analyzed using Adonis, in the Vegan package50,51. Repeated measures analysis 
was conducted and significant time-treatment interactions were investigated with the Vegan package. (*) 
indicates statistical significance at each time point relative to controls.
www.nature.com/scientificreports/
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and small intestine (jejunum) is shown between control (Fig. 8C) and TCC exposed neonates (Fig. 8D) at PND 
12. No apparent histological differences were noted between the two groups.
Figure 6. Comparison of the principal coordinate analysis of weighted UniFrac distances among samples 
collected from (A) control dams (gray circles, n = 4) at GD 18 and samples collected from their offspring (n = 3) 
at PNDs 3 (triangle), 6 (square), 12 (cross) and 16 (star); (B): 0.1% w/w TCC exposed dams (black circles, n = 4) 
at GD 18 and samples collected from their offspring (n = 3) at PNDs 3 (triangle), 6 (square), 12 (cross) and 16 
(star).
Figure 7. Relative abundance of bacteria among neonates at the phylum (A) and family (B) levels by collection 
date at PNDs 3, 6, 12 and 16 (n = 3/group). At the family level, only the top 50 OTUs are shown. Taxon labels 
within square brackets indicate GreenGenes proposed taxonomy.
www.nature.com/scientificreports/
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Phylum* Stain Group
Least Squares Means**
PND 3 PND 6 PND 12 PND 16
BacteroidetesAB Gram − 
Control 22.6 < 1 50.3 64.8
Exposed 9.0 < 1 9.4 21.3
FirmicutesA Gram + 
Control 41.0 11.9 7.2 25.2
Exposed 37.7 5.8 2.4 < 1
ProteobacteriaB Gram − 
Control 35.3 87.3 34.0 7.5
Exposed 52.7 94.0 88.2 78.0
Table 3. Effect of TCC on Relative Abundance of Neonate Gut Microbial Phyla. A = Effect of time, p < 0.05; 
B = Effect of treatment, p < 0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1% of 
the relative abundance. **Least squares means displayed as percentage; PND = postnatal day.
Family* Stain Group
Least Squares Means**
PND 3 PND 6 PND 12 PND 16
BacteroidaceaeABC Gram − 
Control 12.8 < 1 48.4 39.6
Exposed 7.5 < 1 1.0 18.1
EnterobacteriaceaeB Gram − 
Control 33.3 82.1 32.4 7.2
Exposed 51.3 93.7 88.0 77.9
PasteurellaceaeABC Gram − 
Control < 1 5.2 1.5 < 1
Exposed < 1 < 1 < 1 < 1
S24− 7ABC Uncultured
Control 6.9 < 1 1.9 16.5
Exposed < 1 < 1 < 1 < 1
Table 4. Effect of TCC on Relative Abundance of Neonate Gut Microbial Families. A = Effect of time, 
p < 0.05; B = Effect of treatment, p < 0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise 
≥ 1% of the relative abundance. **Least squares means displayed as percentage; PND = postnatal day.
Figure 8. Representative histology of formalin fixed gross gastrointestinal morphology in control (A) and 
0.1% w/w TCC (B) exposed male neonates at PND 12. Large intestine (cecum) and small intestine (jejunum) is 
shown from control (C) and 0.1% w/w TCC (D) exposed neonates at PND 12 (H&E, 20X).
www.nature.com/scientificreports/
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Discussion
It is common to choose non-prescription antimicrobial containing products for prophylactic reasons11,12. 
TCC has been detected in human serum and cord blood suggesting a systemic distribution of this hydro-
phobic compound through maternal circulation16,17. Hydrophobic drugs are likely to concentrate in breast 
milk because of the high lipid load22. Detection of TCC is reported in human milk, implying that as the nat-
ural and optimal food for infants, breast milk may serve as the primary exposure route to TCC among breast-
fed infants23. We recently demonstrated that TCC was transferred through the milk to suckling neonates21. 
Pups exposed to TCC through lactation had distended gastrointestinal tracts with liquid, mustard-colored 
diarrhea. Further, the concentration of TCC identified in the milk of exposed dams was four times higher 
than the corresponding levels found in maternal circulation21. The potential TCC exposure among nurs-
ing infants dictates the need to investigate the effect of TCC on the gut microbiota composition during 
early life.
In this study, to understand the development of gut microbial community structure in neonatal rats and 
understand the dynamics of pregnant/lactating rats in response to TCC exposure, fecal/cecum material were 
collected at specific time-points during gestation and lactation. Provision of TCC during gestation and lactation 
altered the community structure of dam fecal microbiota over time. In dams, alpha diversity was significantly 
reduced in exposed animals at all collection dates after baseline (Fig. 1A,B). Beta diversity was significantly dis-
similar on both GD 18 during gestation and 16 days post-delivery (AD 16) in exposed compared to control dams 
(Fig. 2, Supplementary Fig. S1). Weighted UniFrac Adonis stratified to each sample over time revealed a signif-
icant interaction between time and treatment that occurred at GD 11. Here, distances remain relatively stable 
among exposed dams across the study while microbial distance among control animals becomes more dynamic 
after GD 11 (Supplementary Fig. S1). Thus, it appears that TCC as an antimicrobial confines distance of exposed 
dams relative to controls.
In the dam, the effect of TCC exposure on beta and alpha diversity was mirrored in the microbial relative 
abundance at the phylum and family level (Fig. 3A,B). As shown in Table 1 and Table 2, the majority of microbi-
ota that increased in relative abundance following exposure to 0.1% w/w TCC, stain Gram-negative. In addition, 
Clostridiaceae, Lactobacillaceae and Turicibacteraceae that stain Gram-positive, made up a significantly increased 
proportion of the relative abundance in control samples compared to TCC exposed samples. This is not altogether 
surprising given that TCC shows primary efficacy for Gram-positive bacteria24. This selectivity could allow for the 
overgrowth of potentially pathogenic Gram-negative strains. Though overt signs of infection were not observed 
in the dam. Because we did not observe adverse gastrointestinal reactions (i.e. diarrhea) in the adult animals 
during the study period, histological assessment was not conducted.
During early life, one view of antibiotic-induced dysbiosis purports that the gut microbiome responds to 
prescription antibiotics with the loss of keystone taxa and metabolic shifts in the short-term5. Even after antibi-
otic treatment ends, keystone taxa may not have recovered and the loss of diversity could allow for the bloom of 
pathogens and pathobionts. In this study, unexposed neonatal communities became more diverse over time while 
TCC exposure, like prescription antibiotics5, restricted diversity of colonizing species during the same period 
(Fig. 4A,B). The health outcomes of this taxa loss remain to be determined.
Among suckling neonates, TCC exposure led to microbial diversity loss. Within cecum samples collected 
from exposed neonates, visually the overall alpha diversity declined overtime with significant suppression of 
phylogenetic diversity at PND 16 (Fig. 4B) compared to controls. A similar pattern developed when neonatal beta 
diversity was evaluated, whereby in control and TCC exposed neonates, an initial stochastic pattern emerged at 
PND 3. At PND 6, an overall restructuring occurred where control and TCC exposed communities converged. 
Starting from PND 12, communities separated based on exposure status and became significantly different at 
PND 16 (Fig. 5, Supplementary Fig. S2). The overall restructuring that occurred among samples collected from 
control neonates at PND 6 was interesting, though may provide an indication of the normal colonization process. 
Using Friend leukemia virus B mice, Pantoja-Feliciano et al. demonstrated suppressed diversity at PND 3 and 9, 
compared to day 1, that increased again to levels similar to dams at PND 2125. Additionally, Palmer et al. reported 
that the mean Pearson’s correlation between human infant and adult fecal microbiota increased from day 0 until 
around day 5 post-birth, when an apparent population rearrangement occurred resulting in the divergence from 
adult samples7. Thereafter, infant microbial profiles again correlated more closely to adults throughout the first 
18 months of life.
We demonstrated that distances of samples from control neonates at PND 3 clustered around microbiota of 
control dams at GD 18 (Fig. 6A). By PND 6, a population shift occurred, with movement of neonates away from 
that of dams. At PNDs 12 and 16, the neonatal distance from dams decreased at each respective time-point. 
Microbiota may initially be acquired and only those microbes that can occupy the niche specific to the infant gut 
will colonize5. We postulate that among control neonates, the initial dam-neonate similarity reflects the microbi-
ota transferred either from the dam or environment over the first few days of life. At PND 6, only those microbes 
that can occupy the neonatal cecum biome propagate. This in turn produces a more hospitable microbial environ-
ment, driving increased diversity and similarity to adult dam samples at PNDs 12 and PND 16.
The distance similarity noted between control dams at GD 18 and neonates at PND 3 was not demonstrated 
among TCC exposed dams and their neonates (Fig. 6B). Here, among exposed neonates, early life TCC exposure 
constrained the progression to a more diverse state. One limitation of this study design was that samples were 
not collected prior to PND 3. Thus we cannot comment on the potential similarity of TCC exposed neonatal 
microbiota to dams at the time of delivery. Furthermore, because exposure during gestation and lactation was 
not separated, we could not dissect the effect of early microbial restriction at gestation or lactation individually. 
Previously, we demonstrated that TCC could cross the placental barrier and was detected in the amniotic fluid21. 
Further, research now indicates that microbial establishment may occur prenatally26. Thus, we could not rule out 
the possibility that restriction demonstrated in TCC exposed neonates was an outcome of gestational exposure. 
www.nature.com/scientificreports/
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Cesarean-section or a cross-fostering design could be utilized in the future to separate the effect of TCC expo-
sure between gestation and lactation. Further, sample collection at the time of parturition would provide further 
insight into the normal colonization process at early life stages.
Additional limitations such as the small sample size (n = 4 dams, and n = 3 neonates) and the fact that the neo-
natal samples were pooled is noted. Pooling samples reduces variability, but could also reduce the overall sample 
number and statistical power. However, because TCC was administered through the chow to dams and neonatal 
exposure occurred through the milk to the whole litter, statistical analysis based on the whole litter instead of 
using individual neonates within each litter has been proposed27. Specifically, it might not be an ideal situation to 
collect two sibling neonates from a single litter and consider these two animals as separate experimental units. In 
this study, we pooled neonates collected from separate cages within each treatment group in order to reduce the 
variability that might be demonstrated if only a single neonate were collected at each time point. Future investi-
gation with increased dam numbers producing larger neonatal sample size would strengthen the power of these 
studies.
The infant gut is first colonized by facultative anaerobes such as Enterobacteriaceae that lower the redox poten-
tial allowing for growth of strictly anaerobic bacteria28. Among neonates at PND 3, Enterobacteriaceae domi-
nated in both control and treated groups (Fig. 7B, Table 4). After PND 6, Bacteroidaceae gained a stronghold in 
control samples becoming significantly enhanced compared to exposed samples overtime (Table 4). In contrast, 
Enterobacteriaceae maintained dominance in TCC exposed samples from PND 6 until the end of the study period 
and repeated measures analysis revealed a significant effect of treatment group compared to control samples 
(Table 4). The relative contribution of Enterobacteriaceae may explain the convergence at PND 6. Because TCC 
shows selective efficacy for Gram-positive bacterial strains24, if mostly Gram-negative bacteria dominated at PND 
6 in both groups, the effect of TCC may be minimal. However, with consistent exposure few Gram-positive bacte-
ria, for example, may colonize overtime contributing to the diversity difference between the two groups.
Currently the specific cause of diarrhea in exposed animals is elusive. It is possible that exposure to TCC 
allowed for colonization of pathogenic members of the Enterobacteriaceae family and subsequent infection. 
Because samples were pooled, if only certain neonates of a pool were colonized by a pathogenic strain of E.coli, for 
example, the total contribution might be minimized and infection based solely on microbial abundance may be 
overlooked. However, all TCC exposed neonates displayed distended abdomens (Fig. 8B) and diarrhea, indicating 
that if infection/diarrhea was the result of an overgrowth of a certain member of the Enterobacteriaceae family, 
pooling samples would not mask the effect. Enterobacteriaceae bloom in the gut microbiota is documented among 
human infants in response to prescription antibiotics and is associated with potentially life threatening diseases 
such as necrotizing enterocolitis29–31. Furthermore, a reduction in the ratio of Bacteriodeace to Enterobacteriaceae 
of the human infant gut is indicated in later-life health outcomes, such as food sensitivities32. Collectively, our 
results should drive future research regarding both short and long-term health consequences related to TCC 
exposure in humans, specifically during early life.
It was interesting to note that exposed neonates showed distended abdomens (Fig. 8B) with mustard-colored 
diarrhea, though no apparent histopathological differences were identified (Fig. 8C,D). Currently, the mechanism 
of TCC-induced diarrhea among the neonates is unknown. However, given its antimicrobial nature, TCC may act 
similarly to prescription antibiotics. The use of many prescription drugs, including antibiotics, can lead to diar-
rhea onset, commonly without organic lesions33. Antibiotic-associated diarrhea (AAD) is unexplained diarrhea 
that is associated with antibiotic administration34. The mechanisms of AAD are diverse and may be related to the 
pharmacokinetic properties of the drug itself or to suppression of the gut microbiota. Future investigation may 
benefit from the use of gnobiotic animals to rule out the interaction of TCC on the gut microbiota to determine 
whether diarrhea was a primary effect of TCC exposure or secondary to its action on the gut microbiota.
Conclusion
Oscillations in the gut microbial community structure can occur with exposure to prescription antibiotics lead-
ing to dysbiosis of the gut ecosystem35. These compositional changes can induce opportunistic pathogen over-
growth resulting in infectious disease (i.e. C. difficile infection) in the short-term and chronic disease (i.e. asthma) 
throughout life. Like prescription antibiotics, we demonstrated the ability of a non-prescription antimicrobial 
TCC, to induced gut microbial dysbiosis during sensitive exposure windows in a rat model. Collectively, our 
results add to the growing public concern related to the potential human health impact of non-prescription anti-
microbial exposure and should guide regulatory agencies in policy decisions regarding the use of non-prescription 
antimicrobials in personal care products during critical physiological stages.
Materials and Methods
Animals and Husbandry. Timed-pregnant Sprague Dawley (SD) rats were purchased from Harlan 
Laboratory (Dublin, VA). The day after mating was designated as gestational day (GD) 1. Upon arrival, ani-
mals were weight ranked and randomly assigned to control or treatment groups (n = 4/group). Animals were 
housed individually under specified conditions (12:12-hour light cycle, temperature of 20 °C to 22 °C, and relative 
humidity of 40% to 50%) with ad libitum access to water and commercial Harlan ground 2020X chow or 2020X 
supplemented with 0.1% w/w TCC (purity 99%, Sigma Aldrich, St Louis, Missouri) daily from GD 4 until 16 
days after delivery. This period was chosen as we demonstrated that TCC could cross the placental barrier and 
accumulate in the milk of lactating rats21. We previously demonstrated that the serum TCC concentration of 
pregnant rats after oral exposure to 0.2% w/w TCC was similar to or within an order of magnitude of the concen-
trations reported in the blood of human volunteers, specifically in those who were regular users of TCC contain-
ing soap21,36. Parturition occurred naturally. The Animal Use and Care Committee at the University of Tennessee, 
Knoxville, approved all study protocols. All methods were conducted in accordance with the Institutional Animal 
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Care and Use Committee (IACUC) guidelines. This investigation was conducted in an animal facility fully accred-
ited by the Association for Assessment and Accreditation of Laboratory Animal Care.
Fecal/cecum Sample Collection. Fecal samples from dams (n = 4/group) and cecum content (n = 3/
group) from neonates were collected at designated dates throughout gestation and lactation. Briefly, for fecal col-
lection, an individual dam was removed from the home cage and placed in a clean cage free of bedding. The tail of 
the rat was lifted to facilitate the discharge of feces. Stainless steel forceps were used to collect fecal pellets imme-
diately after the samples were produced. All tools were autoclaved prior to use and changed between cages. Fecal 
samples were collected at baseline (GD 4), 7 days post-treatment (GD 11), 14 days post-treatment (GD 18), and 
16 days after delivery (AD) corresponding to 34 days after the initiation of exposure regimen. No fecal samples 
were collected from dams between GD 18 and any days prior to the final day of the study to reduce disturbance 
prior to the delivery and during lactation.
Collection of cecum content from neonates was a terminal procedure. Samples were collected between 8:00 
AM and 12:00 PM on the day of sacrifice. At postnatal day (PNDs) 3, 6, 12 and 16, within each group, two female 
neonates were randomly selected from each dam. Cecum content from each neonate was removed and combined 
into three pools so that no individual pool contained two neonates born to the same dam. The maternal origin of 
the composition of each pool was made consistent at each subsequent collection date. In other words, if cecum 
content from a neonate born to a specific dam was added to a designated pool on PND 3, cecum content from an 
additional neonate born to the same dam was used to create the same pool on PND 6. Fecal/cecum samples were 
snap frozen immediately following collection and stored at − 80 ° C until analysis.
Neonatal Histology. At PND 12, neonatal gastrointestinal tracts (jejunum and cecum) were collected from 
male neonates with or without TCC exposure during lactation and fixed in 10% formalin. Tissue sections were 
examined with hematoxylin-eosin (H&E) staining. A board-certified pathologist, blinded to treatment status, 
evaluated histological changes.
DNA Isolation, Amplification, and 16S rRNA Sequencing. DNA Extraction, Amplification and 
Clean-up. DNA was extracted from frozen fecal/cecum samples with the Power fecal DNA isolation kit (Mo Bio 
Laboratories, Inc. Carlsbad, CA) following manufacturer’s instructions. Extracted DNA samples were quantified 
with Nanodrop 1000™ and stored at − 80 °C until PCR amplification. DNA was amplified by targeting the V4 
region of the bacterial 16S rRNA gene as described by Caporaso et al.37.
The initial PCR product was purified with DNA gel electrophoresis to remove DNA impurities and primer 
dimers. The concentration of purified amplicon product was measured with Qubit dsDNA HS Assay Kit (Life 
Technologies, Carlsbad, CA) and normalized to an equal concentration to create a single amplicon pool.
Bacterial Barcoded Amplicon Library Preparation, Sequencing and Sequence Analysis. Beads 
Clean-up. Pooled amplicons were purified with SPRIselect (Beckman Coulter, Inc., Indianapolis, IN) following 
the manufacturer’s protocol (Next-flex™ 16S V4 Amplicon Seq-kit manual). The products were analyzed with 
Agilent High Sensitivity DNA Analysis (CHIP) Kit for quality assurance on a 2100 Bioanalyzer (Agilent, Santa 
Clara, CA).
Library Quantification and Illumina Sequencing. The pooled amplicon library concentration was quantified 
with the Illumina Library Quantification kit (KAPA Biosystems, Boston, MA) prior to sequencing. Quantitative
PCR was performed with the KAPA SYBR® FAST qPCR Master Mix (2X). The amplicon library was diluted to 
a starting concentration of 10 nM and sequenced on the Illumina MiSeq sequencer (Illumina, Inc., San Diego, CA).
Sequence Data Analysis. The resulting raw sequencing data was analyzed using the QIIME (v1.8.0) pipeline38. 
Unless otherwise stated all python scripts reside within QIIME. The script, join_paired_ends.py, was used to 
generate the assembled paired-end reads. Next, paired-end sequences were demultiplexed and quality filtered 
with Phred score no less than 20. The UCHIME program was used to detect chimeras on assembled reads via 
identify_chimeric_seqs.py39. Operational taxonomic units (OTU) were generated using the script, pick_open_
reference_otus.py, with 97% similarity via USEARCH40,41. The OTU taxonomy was assigned using the Ribosomal 
Database Project (RDP) classifier42 with the May 2013 Greengenes release in QIIME43,44, and then aligned via 
PyNAST45. Any OTU present at less than 0.005% of the total read count was filtered to remove the potential 
influence of spurious OTUs46,47. The resulting filtered output was used to make a phylogeny (make_phylogeny.
py). The phylogeny was then rooted to Bacteroidetes. All samples were rarefied at a minimum sequencing depth 
of 55,000 OTUs. The script alpha_rarefaction.py was used to confirm the appropriate minimum sequencing depth 
across samples. 16S datasets were deposited in the Sequence Read Archive under accession number: SRP067613.
Statistics. Statistical analysis was conducted in R (version 3.1.2) using Phyloseq unless otherwise noted48. 
Microbial community composition by treatment group at each fecal/cecum collection date was visualized using 
Principal Coordinate Analysis (PcoA) and boxplots constructed with weighted UniFrac distances49. Community 
level statistical significance was tested with the nonparametric Adonis function in the Vegan package at each 
individual time-point50,51. Adonis permutations were stratified by collection date among neonates in the Vegan 
package to account for sampling across time. A repeated measures permanova was conducted on dam samples 
stratified by rat ID using the BiodiversityR package, with separate whole and sub-plot analyses52. Post-hoc analysis 
of repeated measures Adonis results were analyzed with the Vegan package to dissect significant time-treatment 
interactions. Within sample richness and evenness were estimated using Shannon’s index. Faith’s phylodiversity 
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(PD) metric was calculated via QIIME53. Dam alpha diversity estimates were analyzed using two-way ANOVA 
with repeated measures and neonate alpha diversity was analyze by ANCOVA using dam GD 18 alpha diversity as 
a covariate in SigmaPlot (version 13) with Bonferroni post-hoc test. Data were presented as group mean ± SEM. 
Relative abundance of OTUs at the phyla and family level were visualized with Phyloseq48. Statistical significance 
was set at alpha = 0.05. Relative abundance was analyzed statistically using the glm function in R. Time and treat-
ment fixed effects were analyzed with ANOVA and Fisher’s LSD mean separation (lsmeans package)54.
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